West-Ward, the U.S. division of Hikma Pharmaceuticals, announced the availability of Mitigare (colchicine) capsules and its authorized generic for the prophylaxis of gout flares in adults. Colchicine ...
London, 10 October 2014 - Hikma Pharmaceuticals PLC ("Hikma") (LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY), the fast growing multinational pharmaceutical group, today notes that the United States ...
London, 12 January 2015 - Hikma Pharmaceuticals PLC ("Hikma") (LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY), the fast growing multinational pharmaceutical group, today notes that Takeda Pharmaceuticals ...
DUBLIN, Nov. 2, 2023 /CNW/ -- Endo International plc (OTC: ENDPQ) announced today that one of its operating companies, Par Pharmaceutical, Inc., has begun shipping colchicine 0.6 mg capsules, a ...
Overview: Colchicine tablets, capsules, and liquid are used to reduce complications from coronary artery disease, treat Familial Mediterranean Fever, and treat or prevent gout attacks. The most common ...
Colchicine is a generic prescription medication used to prevent gout flares and treat familial Mediterranean fever (FMF) in adults and certain children. Like most drugs, colchicine can cause side ...
Hikma Pharmaceuticals PLC ("Hikma") , the fast growing multinational pharmaceutical group, today notes that Takeda Pharmaceuticals U.S.A. Inc. ("Takeda") has been unsuccessful in appealing the ...